Hello, Guest
Login
Sign Up
 
 

Major Drug Manufacturers Stocks: Aegerion Pharmaceuticals, Pacira Pharmaceuticals Inc, Impax Laboratories Inc, Novartis AG

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 02/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Aegerion Pharmaceuticals, Inc.(NASDAQ:AEGR) added 3.83% and is trading at $30.50. Aegerion Pharmaceuticals, Inc. (Aegerio) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat lipid disorders. As of December 31, 2011, the Company developed its first product candidate, lomitapide, as an oral, once-a-day treatment for patients with a inherited lipid disorder called homozygous familial hypercholesterolemia (HoFH).

How Should Investors Trade AEGR After The Recent Movement? Find Out Here

Pacira Pharmaceuticals Inc(NASDAQ:PCRX) is higher 3.58% and is trading at $21.62. Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control.

Is PCRX Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Impax Laboratories Inc(NASDAQ:IPXL) added 3.26% and is trading at $19.98. Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company. The Company is engaged in development, manufacture and marketing of bio-equivalent pharmaceutical products, referred to as generics, in addition to the development of branded products.

Is IPXL a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Novartis AG (ADR)(NYSE:NVS) is higher 0.90% and is trading at $67.35. Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals.

How Should Investors Trade NVS After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.